Designed for the measurement of MxA protein in human whole blood, an innovative ELISA based on the use of patented monoclonal antibodies and a special buffer to extract the cytoplasmic MxA protein is suitable for the monitoring of IFN-β therapy in multiple sclerosis patients and for viral infection recognition. Human Myxovirus protein A is induced exclusively by IFN-α and IFN-β. Since direct measurement of the IFN levels in plasma is difficult, MxA may be useful as a marker distinguishing viral disease from bacterial infection or from acute graft-versus-host disease after allogenic stem cell transplantation. Neutralizing antibodies may develop during the IFN-β therapy of multiple sclerosis and lead to loss of drug bioactivity. The IFN-β-inducible MxA protein is an ideal marker of IFN-β bioavailability, capable of discriminating between biologically responsive and non-responsive patients. The BioVendor assay meets all the requirements for routine clinical use in manual mode as well as on open ELISA robotic systems. Read more
https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C304_BioVendor.jpg1501003wmediahttps://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png3wmedia2020-08-26 09:19:532021-01-08 11:28:59Human MxA Protein ELISA
Designed for daily use in small labs and providing all the qualities of a high throughput qualitative instrument at an affordable rate, the ZENIX 2200 features a high quality optical system, using semi-reflective mirrors and cuvettes with excellent UV penetrability for the same level of sensitivity as the best systems on the market. Efficiency is increased thanks to its independent washing station, 44 reagent and 44 sample capacity rotors and its comprehensive software compatible with Windows® 7, Vista and XP. With a throughput of 200 tests/hour, the instrument also uses automatic dilution and retesting when concentrations are outside limits. Its maintenance-free micro pump and easy access to internal systems optimize maintenance and allow for quick and easy servicing. Read more
https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C307_SFRI_Zenix-2200.jpg1001503wmediahttps://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png3wmedia2020-08-26 09:19:532021-01-08 11:28:58Automated random access analyser
Two new Anti-Hepatitis E Virus (HEV) ELISAs provide reliable detection of HEVspecific antibodies of class IgG and IgM. The IgG ELISA is, moreover, the only commercial HEV ELISA to provide quantification in international units (IU/ml). The assay is calibrated according to the WHO reference serum and shows first-rate linearity with respect to this standard. The ELISA microplates are coated with highly purified recombinant HEV structural proteins, which ensure high sensitivity and specificity in antibody detection. The Anti-HEV ELISAs are ideal for differential diagnosis, for epidemiological studies and, in combination with PCR, for blood donor screening. The tests are easy to perform and can be fully automated on microplate processing systems such as the company’s Analyzer series. Infections with HEV are the most frequent cause on non-A, non-B hepatitis worldwide. They are generally acquired fecal-orally via contaminated drinking water or food (e.g. insufficiently cooked pork). HEV is endemic primarily in countries with low standards of hygiene, but is also increasingly observed in industrialized nations. HEV infections generally take a mild course, but in rare cases they can lead to acute liver failure. Prognosis is particularly poor in pregnant women, and in this group the mortality rate reaches up to 20%. Since an HEV infection resembles hepatitis A and other hepatides in the preliminary stages, differential diagnostic tests as part of the clinical and laboratory investigation are essential. Alongside PCR analysis of viral RNA in blood or stool, the serological detection of HEV-specific IgM and IgG antibodies plays a decisive role in acute HEV diagnostics. Read more
A new generic chemistry reagent line, packaged in a bar-coded bottle, allows easy application to the Beckman Coulter AUTM 400/480/640 chemistry analysers. This direct-placement packaging reduces both technician time and the potential for costly errors, while providing greater operator convenience and ease-of-use by enabling automated on-board reagent management. This line also has the potential to offer significant cost savings over the instrument manufacturer’s branded reagents. The liquid stable formulations show excellent accuracy and precision. Available products in this line include reagents to perform BMP’s, CMP’s, Lipid Panels, Renal Panels, Hepatic Panels, and other general chemistry tests. Read more
https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C295_PointeSci_PI-O1111-01.jpg1061503wmediahttps://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png3wmedia2020-08-26 09:19:532021-01-08 11:28:58Bar-coded chemistry reagent line
Bio/Data Corporation is now offering a Tele-Check✓™ Calibration Verification Service for its platelet aggregometers. This calibration verification is performed over the phone while the aggregometer remains in the laboratory and is available for the PAP-8E and PAP-4 Series aggregometers in good working order. This service reduces downtime, save costs, and assures the platelet aggregometer is performing to published specifications. A service technician guides the user through the calibration verification process. Required materials are shipped to the laboratory in advance of the scheduled Tele-Check appointment. Calibration results generated by the instrument are submitted by the laboratory to the company for review by a Quality Control representative. Upon approval, a Certificate of Calibration will be issued along with a Calibration Sticker. Read more
https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C297_BioDataCorp.jpg1501003wmediahttps://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png3wmedia2020-08-26 09:19:532021-01-08 11:28:58Calibration verification service for platelet aggregation testing
Helicobacter pylori (H. pylori) is a cork-screw-spiral-like gram-negative bacterium that has adapted to grow in the human stomach. The prevalence of H. pylori infection worldwide is approximately 66%, and in developing countries, it is as high as 80% – 90%. The testing and treatment of H. pylori is very important as it has been estimated that up to 20% of people infected with H. pylori will develop ulcers which may lead to specific cancers. MP Diagnostics ASSURE H. pylori Rapid Test and Helico Blot 2.1 Western Blot incorporate a unique marker, CIM, which is used to detect the current infection of H. pylori bacteria. CIM stands for Current Infection Marker which is actually a H. pylori-specific protein. The nucleotide sequence of the CIM antigen is homologous to a conserved secreted protein. This protein has been found to be highly immunogenic for detection of H. pylori infected patients with high Positive Predictive Value of >90%. It has been coined as Current Infection Marker because IgG antibodies for CIM have been found in patients with active H. pylori infection. These patients are confirmed to have active H. pylori infection by two or more active infection diagnostic tests such as rapid urease test, culture, histology, and Urea Breath Test. With CIM-based products, no additional tests are needed for detecting current H. pylori infection. Read more
https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C302_MPbiomedicals.jpg831503wmediahttps://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png3wmedia2020-08-26 09:19:532021-01-08 11:28:57H. pylori rapid test
Rapid, simultaneous detection of respiratory pathogens
The Respiratory Multiplex Array is intended for the simultaneous detection of 22 bacterial and viral respiratory pathogens in individuals suspected of Respiratory Tract Infections. The ability to simultaneously detect these in one sample provides clinicians with a complete patient profile, enabling faster and more appropriate treatment decisions.
The Respiratory Multiplex Array is based on a combination of multiplex PCR, biochip hybridization and chemiluminescence detection using the Evidence Investigator analyser. The array can run 54 samples simultaneously in five hours. Identifying multiple pathogens will provide a rapid and more cost-effective diagnostic tool than current methods – which only look for single pathogens – thus reducing the time from presentation to treatment and minimizing sample requirements. Save time and costs associated with single pathogen detection by using the Respiratory Multiplex Array.
Randox is helping in the fight against unwanted disease
Sexually Transmitted Infections (STIs) have become a wearisome issue for healthcare systems across the globe. Early and correct diagnosis of STIs is essential as they can lead to other major health issues. Undiagnosed STIs can spread uncontrollably.
With the ability to simultaneously detect 10 STI pathogens, the STI array far exceeds other STI tests currently available. Its rapid multiplexing capabilities allow it to detect the following pathogens: chlamydia trachomonas, neisseria gonorrhea, trichomonas vaginalis, treponema pallidum, herpes simplex I, herpes simplex II, mycoplasma hominis, mycoplasma genitalium, ureaplasm urealyticum, haemophilus ducreyi.
Through simultaneous testing for multiple STI pathogens, specific viral, protozoan or bacterial pathogens can be identified, thus resulting in a targeted antibiotic response. This can also identify secondary infections which could have been missed.
Resistant to Xylene, MEK, IPA, DMSO, etc, Laboratory Labelling Specialists CILS have launched the ultimate solvent-resistant, computer printable durable label – Perfect for microscope slides, HPLC columns, tissue cassettes, vials, tubes etc.
Printable straight from a standard Laser or Thermal Transfer printer, variable data (batch no’s, barcodes etc) can be added ‘in minutes’, saving time and eliminating the risk of smudged/illegible handwritten data.
The specially formulated CILS-8100S computer imprintable surface coating ensures all variable data remains clear and legible under extreme solvent exposure without any secondary laminates or tape.
For more information on the CILS solvent resistant laboratory label range, visit:http://www.cils-international.com/content/cils-ultra-solvent-resistant-labels Read more
https://clinlabint.com/wp-content/uploads/sites/2/2020/08/cils_01.jpg1241503wmediahttps://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png3wmedia2020-08-26 09:19:532021-01-08 11:28:56CILS-8100S The Most Solvent-Resistant CILS Label Yet
BIO-FLASH is a rapid-response chemiluminescent analyser for use by clinical reference and hospital laboratories. It offers full automation of a broad menu of highly accurate QUANTA Flash immunoassays for autoimmunity testing. Tests that previously required significant hands-on time can now be automated on an intuitive and rapid system. BIO-FLASH and the QUANTA Flash reagents are classified as moderately complex under the Clinical Laboratories Improvements Act (CLIA), making the system accessible to a wide range of laboratories and their staff. The first result is generated in as little as 30 minutes, with additional results generated one per minute thereafter. The analyser incorporates chemiluminescent technology, representing an important advance in accuracy and precision for immunoassay testing. Other benefits of the system include an increased analytical measuring range, onboard dilution and stored calibration. A comprehensive menu of QUANTA Flash reagents is available, including tests to aid in the diagnosis of celiac disease, vasculitis, antiphospholipid syndrome and connective tissue diseases. This menu will continue to expand as INOVA develops additional autoimmune assays. Read more
We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.
Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.
Essential Website Cookies
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.
We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.
We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.
.
Google Analytics Cookies
These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.
If you do not want us to track your visit to our site, you can disable this in your browser here:
.
Other external services
We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page
Google Webfont Settings:
Google Maps Settings:
Google reCaptcha settings:
Vimeo and Youtube videos embedding:
.
Privacy Beleid
U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.
Human MxA Protein ELISA
, /in Product News /by 3wmediaDesigned for the measurement of MxA protein in human whole blood, an innovative ELISA based on the use of patented monoclonal antibodies and a special buffer to extract the cytoplasmic MxA protein is suitable for the monitoring of IFN-β therapy in multiple sclerosis patients and for viral infection recognition. Human Myxovirus protein A is induced exclusively by IFN-α and IFN-β. Since direct measurement of the IFN levels in plasma is difficult, MxA may be useful as a marker distinguishing viral disease from bacterial infection or from acute graft-versus-host disease after allogenic stem cell transplantation. Neutralizing antibodies may develop during the IFN-β therapy of multiple sclerosis and lead to loss of drug bioactivity. The IFN-β-inducible MxA protein is an ideal marker of IFN-β bioavailability, capable of discriminating between biologically responsive and non-responsive patients. The BioVendor assay meets all the requirements for routine clinical use in manual mode as well as on open ELISA robotic systems.
Read more
Automated random access analyser
, /in Product News /by 3wmediaDesigned for daily use in small labs and providing all the qualities of a high throughput qualitative instrument at an affordable rate, the ZENIX 2200 features a high quality optical system, using semi-reflective mirrors and cuvettes with excellent UV penetrability for the same level of sensitivity as the best systems on the market. Efficiency is increased thanks to its independent washing station, 44 reagent and 44 sample capacity rotors and its comprehensive software compatible with Windows® 7, Vista and XP. With a throughput of 200 tests/hour, the instrument also uses automatic dilution and retesting when concentrations are outside limits. Its maintenance-free micro pump and easy access to internal systems optimize maintenance and allow for quick and easy servicing.
Read more
HEV ELISAs
, /in Product News /by 3wmediaTwo new Anti-Hepatitis E Virus (HEV) ELISAs provide reliable detection of HEVspecific antibodies of class IgG and IgM. The IgG ELISA is, moreover, the only commercial HEV ELISA to provide quantification in international units (IU/ml). The assay is calibrated according to the WHO reference serum and shows first-rate linearity with respect to this standard. The ELISA microplates are coated with highly purified recombinant HEV structural proteins, which ensure high sensitivity and specificity in antibody detection. The Anti-HEV ELISAs are ideal for differential diagnosis, for epidemiological studies and, in combination with PCR, for blood donor screening. The tests are easy to perform and can be fully automated on microplate processing systems such as the company’s Analyzer series. Infections with HEV are the most frequent cause on non-A, non-B hepatitis worldwide. They are generally acquired fecal-orally via contaminated drinking water or food (e.g. insufficiently cooked pork). HEV is endemic primarily in countries with low standards of hygiene, but is also increasingly observed in industrialized nations. HEV infections generally take a mild course, but in rare cases they can lead to acute liver failure. Prognosis is particularly poor in pregnant women, and in this group the mortality rate reaches up to 20%. Since an HEV infection resembles hepatitis A and other hepatides in the preliminary stages, differential diagnostic tests as part of the clinical and laboratory investigation are essential. Alongside PCR analysis of viral RNA in blood or stool, the serological detection of HEV-specific IgM and IgG antibodies plays a decisive role in acute HEV diagnostics.
Read more
Bar-coded chemistry reagent line
, /in Product News /by 3wmediaA new generic chemistry reagent line, packaged in a bar-coded bottle, allows easy application to the Beckman Coulter AUTM 400/480/640 chemistry analysers. This direct-placement packaging reduces both technician time and the potential for costly errors, while providing greater operator convenience and ease-of-use by enabling automated on-board reagent management. This line also has the potential to offer significant cost savings over the instrument manufacturer’s branded reagents. The liquid stable formulations show excellent accuracy and precision. Available products in this line include reagents to perform BMP’s, CMP’s, Lipid Panels, Renal Panels, Hepatic Panels, and other general chemistry tests.
Read more
Calibration verification service for platelet aggregation testing
, /in Product News /by 3wmediaBio/Data Corporation is now offering a Tele-Check✓™ Calibration Verification Service for its platelet aggregometers. This calibration verification is performed over the phone while the aggregometer remains in the laboratory and is available for the PAP-8E and PAP-4 Series aggregometers in good working order. This service reduces downtime, save costs, and assures the platelet aggregometer is performing to published specifications. A service technician guides the user through the calibration verification process. Required materials are shipped to the laboratory in advance of the scheduled Tele-Check appointment. Calibration results generated by the instrument are submitted by the laboratory to the company for review by a Quality Control representative. Upon approval, a Certificate of Calibration will be issued along with a Calibration Sticker.
Read more
H. pylori rapid test
, /in Product News /by 3wmediaHelicobacter pylori (H. pylori) is a cork-screw-spiral-like gram-negative bacterium that has adapted to grow in the human stomach. The prevalence of H. pylori infection worldwide is approximately 66%, and in developing countries, it is as high as 80% – 90%. The testing and treatment of H. pylori is very important as it has been estimated that up to 20% of people infected with H. pylori will develop ulcers which may lead to specific cancers. MP Diagnostics ASSURE H. pylori Rapid Test and Helico Blot 2.1 Western Blot incorporate a unique marker, CIM, which is used to detect the current infection of H. pylori bacteria. CIM stands for Current Infection Marker which is actually a H. pylori-specific protein. The nucleotide sequence of the CIM antigen is homologous to a conserved secreted protein. This protein has been found to be highly immunogenic for detection of H. pylori infected patients with high Positive Predictive Value of >90%. It has been coined as Current Infection Marker because IgG antibodies for CIM have been found in patients with active H. pylori infection. These patients are confirmed to have active H. pylori infection by two or more active infection diagnostic tests such as rapid urease test, culture, histology, and Urea Breath Test. With CIM-based products, no additional tests are needed for detecting current H. pylori infection.
Read more
Respiratory Multiplex Array
, /in Product News /by 3wmediaRapid, simultaneous detection of respiratory pathogens
The Respiratory Multiplex Array is intended for the simultaneous detection of 22 bacterial and viral respiratory pathogens in individuals suspected of Respiratory Tract Infections. The ability to simultaneously detect these in one sample provides clinicians with a complete patient profile, enabling faster and more appropriate treatment decisions.
The Respiratory Multiplex Array is based on a combination of multiplex PCR, biochip hybridization and chemiluminescence detection using the Evidence Investigator analyser. The array can run 54 samples simultaneously in five hours. Identifying multiple pathogens will provide a rapid and more cost-effective diagnostic tool than current methods – which only look for single pathogens – thus reducing the time from presentation to treatment and minimizing sample requirements. Save time and costs associated with single pathogen detection by using the Respiratory Multiplex Array.
Website: http://www.randox.com/respiratory-molecular-test.php
Email: marketing@randox.com
Read more
STI Multiplex Array
, /in Product News /by 3wmediaRandox is helping in the fight against unwanted disease
Sexually Transmitted Infections (STIs) have become a wearisome issue for healthcare systems across the globe. Early and correct diagnosis of STIs is essential as they can lead to other major health issues. Undiagnosed STIs can spread uncontrollably.
With the ability to simultaneously detect 10 STI pathogens, the STI array far exceeds other STI tests currently available. Its rapid multiplexing capabilities allow it to detect the following pathogens: chlamydia trachomonas, neisseria gonorrhea, trichomonas vaginalis, treponema pallidum, herpes simplex I, herpes simplex II, mycoplasma hominis, mycoplasma genitalium, ureaplasm urealyticum, haemophilus ducreyi.
Through simultaneous testing for multiple STI pathogens, specific viral, protozoan or bacterial pathogens can be identified, thus resulting in a targeted antibiotic response. This can also identify secondary infections which could have been missed.
Website: http://www.randox.com/sti-multiplex-pcr-molecular-test.php
Email: marketing@randox.com
Read more
CILS-8100S The Most Solvent-Resistant CILS Label Yet
, /in Product News /by 3wmediaResistant to Xylene, MEK, IPA, DMSO, etc, Laboratory Labelling Specialists CILS have launched the ultimate solvent-resistant, computer printable durable label – Perfect for microscope slides, HPLC columns, tissue cassettes, vials, tubes etc.
Printable straight from a standard Laser or Thermal Transfer printer, variable data (batch no’s, barcodes etc) can be added ‘in minutes’, saving time and eliminating the risk of smudged/illegible handwritten data.
The specially formulated CILS-8100S computer imprintable surface coating ensures all variable data remains clear and legible under extreme solvent exposure without any secondary laminates or tape.
For more information on the CILS solvent resistant laboratory label range, visit:http://www.cils-international.com/content/cils-ultra-solvent-resistant-labels
Read more
Chemiluminescent analyser
, /in Product News /by 3wmediaBIO-FLASH is a rapid-response chemiluminescent analyser for use by clinical reference and hospital laboratories. It offers full automation of a broad menu of highly accurate QUANTA Flash immunoassays for autoimmunity testing. Tests that previously required significant hands-on time can now be automated on an intuitive and rapid system. BIO-FLASH and the QUANTA Flash reagents are classified as moderately complex under the Clinical Laboratories Improvements Act (CLIA), making the system accessible to a wide range of laboratories and their staff. The first result is generated in as little as 30 minutes, with additional results generated one per minute thereafter. The analyser incorporates chemiluminescent technology, representing an important advance in accuracy and precision for immunoassay testing. Other benefits of the system include an increased analytical measuring range, onboard dilution and stored calibration. A comprehensive menu of QUANTA Flash reagents is available, including tests to aid in the diagnosis of celiac disease, vasculitis, antiphospholipid syndrome and connective tissue diseases. This menu will continue to expand as INOVA develops additional autoimmune assays.
Read more